Computerized Neuropsychological Assessment Devices in Multiple Sclerosis: A Systematic Review
Multiple Sclerosis
Wojcik, C. M., Beier, M., et al. (2019).
Multiple Sclerosis, 25(14), 1848-1869.
<div>This systematic review investigates the psychometric properties of computerized neuropsychological assessment device batteries for identifying and monitoring cognitive impairment in individuals with multiple sclerosis (MS).</div>
120 total studies included. 51 studies included in the quantitative synthesis.
<div>Computerized neuropsychological assessment device (CNAD) batteries failed to demonstrate adequate reliability and validity for identifying cognitive impairment in individuals with MS; however, some tests showed promise as useful screening tools or supplements to traditional assessment such as:</div>
<div>
<ul>
<li>Subtests of the Cognitive Drug Research (CDR);</li>
<li>the CogState Brief Battery (CBB);</li>
<li>the NeuroTrax;</li>
<li>the Central Nervous System-Vital Signs (CNSVS);</li>
<li>the Computerized Symbol Digit Modalities Test (C-SDMT);</li>
<li>the Processing Speed Test (PST); and</li>
<li>the Computerized Speed Cognitive Test (CSCT).</li>
</ul>
<div>Additional research is needed to investigate ecological validity and patient-relevant outcomes of CNADs for assessing cognition in individuals with MS.</div>
</div>
